Skip to content
Home/Companies/MedTech/Ad-Tech Medical Instrument

Ad-Tech Medical Instrument

MedTech·US·Exited 2024·Held 4yr
Entry
2020
Hold
4yr
Exit
2024

Who owns Ad-Tech Medical Instrument?

Ad-Tech Medical Instrument was owned by ARCHIMED through MED Platform I (2019 vintage) from 2020 to 2024, exited via Secondary.

Buyer identity and MOIC available on Pro.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Platform I · 2019 · Buyout

Key facts

HQUnited States
SectorMedTech
Exit Type
Secondary
Buyer
MOIC
Exit Year
2024

More from MED Platform I

Other portfolio companies in the same fund.

CARSO
Carso
Active
MedTechFrance· 2021
Ametris (ActiGraph)
Ametris (ActiGraph)
Exited 2026
HealthTechUS· 2020
to
Namsa
Active
MedTechUS· 2020
ZYTOMICS
Zytomics
Active
MedTechGermany· 2020
Bomi Group
Exited 2023
MedTechItaly· 2019
to
Direct Healthcare Group
Exited 2026
MedTechUK· 2019
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Ad-Tech Medical Instrument

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Ad-Tech Medical Instrument?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Ad-Tech Medical Instrument.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue